As a biomarker, SIRT1 exhibited a reduced serum level in Fatty liver disease, Obesity, Frailty, Parkinson, and Alzheimer’s disease, while an increased trend was detected in Anorexia nervosa [1–5]. Here, SIRT1 is linked to obesity due to melanocortin 4 receptor deficiency.